Nasdaq · CIK 0001631574
WVE Wave Life Sciences, Inc.
Insider trading from SEC Form 4. Last filing 5 d ago. Close $3.46 on Oct 9, 2026, 0% from the 52-week low and -84% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Price and insider trades, last year
WVEOct 9, 2026 · close 3.46
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Wave Life Sciences, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | Christian O Henry director sell | $103k 10,500 shares | -39% | - | |
| 33Weak | Paul Bolno President and CEO sell | $1.6M 169,025 shares | -33% | - | |
| 17Weak | Paul Bolno President and CEO sell | $750k 50,000 shares | -19% | - | |
| 39Weak | Paul Bolno President and CEO sell | $734k 51,234 shares | -19% | - | |
| 27Weak | Chris Francis See Remarks sell | $576k 36,000 shares | -100% | - | |
| 48Moderate | Paul Bolno President and CEO sell | $1.4M 90,474 shares | -25% | - | |
| 33Weak | Chris Francis See Remarks sell | $2.9M 208,836 shares | -262% | - |
Transactions
The last 47 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Mark Corrigan director | AGrant or award Common Stock | +10,700 | $0.00 | $0 | 39,515 | 5 d ago |
| Oct 5, 2026 | Christian O Henry director | AGrant or award Common Stock | +10,700 | $0.00 | $0 | 23,400 | 5 d ago |
| Oct 5, 2026 | Ra Capital Management, L.p. director, owner | AGrant or award Common Stockindirect: See footnotes | +10,700 | $0.00 | $0 | 39,515 | 5 d ago |
| Oct 5, 2026 | Heidi L Wagner director | AGrant or award Common Stock | +10,700 | $0.00 | $0 | 55,630 | 5 d ago |
| Oct 5, 2026 | Adrian Rawcliffe director | AGrant or award Common Stock | +10,700 | $0.00 | $0 | 10,700 | 5 d ago |
| Oct 5, 2026 | Gregory L. Verdine director | AGrant or award Common Stock | +10,700 | $0.00 | $0 | 200,917 | 5 d ago |
| Oct 5, 2026 | Ken Takanashi director | AGrant or award Common Stock | +10,700 | $0.00 | $0 | 30,779 | 5 d ago |
| Oct 5, 2026 | Aik Na Tan director | AGrant or award Common Stock | +10,700 | $0.00 | $0 | 35,668 | 5 d ago |
| Oct 5, 2026 | Mark Corrigan director | AGrant or award Stock Option (right to buy)derivative | +64,000 | $0.00 | $0 | 64,000 | 5 d ago |
| Oct 5, 2026 | Heidi L Wagner director | AGrant or award Stock Option (right to buy)derivative | +64,000 | $0.00 | $0 | 64,000 | 5 d ago |
| Oct 5, 2026 | Aik Na Tan director | AGrant or award Stock Option (right to buy)derivative | +64,000 | $0.00 | $0 | 64,000 | 5 d ago |
| Oct 5, 2026 | Adrian Rawcliffe director | AGrant or award Stock Option (right to buy)derivative | +64,000 | $0.00 | $0 | 64,000 | 5 d ago |
| Oct 5, 2026 | Christian O Henry director | AGrant or award Stock Option (right to buy)derivative | +64,000 | $0.00 | $0 | 64,000 | 5 d ago |
| Oct 5, 2026 | Ken Takanashi director | AGrant or award Stock Option (right to buy)derivative | +64,000 | $0.00 | $0 | 64,000 | 5 d ago |
| Oct 5, 2026 | Gregory L. Verdine director | AGrant or award Stock Option (right to buy)derivative | +64,000 | $0.00 | $0 | 64,000 | 5 d ago |
| Oct 5, 2026 | Ra Capital Management, L.p. director, owner | AGrant or award Stock Option (Right to Buy)derivativeindirect: See Footnotes | +64,000 | $0.00 | $0 | 64,000 | 5 d ago |
| Mar 20, 2025 | Christian O Henry director | MOption exercise Ordinary Shares10b5-1 | +10,500 | $9.13 | $96k | 26,615 | Mar 21, 2025 |
| Mar 20, 2025 | Christian O Henry director | SOpen-market sale Ordinary Shares10b5-1 | -10,500 | $9.77 | $103k | 16,115 | Mar 21, 2025 |
| Mar 20, 2025 | Christian O Henry director | MOption exercise Share Option (right to buy)derivative10b5-1 | -10,500 | $0.00 | $0 | 0 | Mar 21, 2025 |
| Mar 7, 2025 | Paul Bolno President and CEO | MOption exercise Ordinary Shares10b5-1 | +169,025 | $2.48 | $419k | 507,376 | Mar 7, 2025 |
| Mar 7, 2025 | Paul Bolno President and CEO | SOpen-market sale Ordinary Shares10b5-1 | -169,025 | $9.57 | $1.6M | 338,351 | Mar 7, 2025 |
| Mar 7, 2025 | Paul Bolno President and CEO | MOption exercise Share Option (right to buy)derivative10b5-1 | -120,966 | $0.00 | $0 | 0 | Mar 7, 2025 |
| Mar 7, 2025 | Paul Bolno President and CEO | MOption exercise Share Option (right to buy)derivative10b5-1 | -48,059 | $0.00 | $0 | 0 | Mar 7, 2025 |
| Feb 4, 2025 | Paul Bolno President and CEO | AGrant or award Ordinary Shares | +121,000 | $0.00 | $0 | 338,351 | Feb 6, 2025 |
| Feb 4, 2025 | Chris Francis See Remarks | AGrant or award Ordinary Shares | +25,000 | $0.00 | $0 | 25,000 | Feb 6, 2025 |
| Feb 4, 2025 | Chris Francis See Remarks | AGrant or award Share Option (right to buy)derivative | +151,000 | $0.00 | $0 | 151,000 | Feb 6, 2025 |
| Feb 4, 2025 | Paul Bolno President and CEO | AGrant or award Share Option (right to buy)derivative | +1,000,000 | $0.00 | $0 | 1,000,000 | Feb 6, 2025 |
| Nov 25, 2024 | Paul Bolno President and CEO | MOption exercise Ordinary Shares10b5-1 | +50,000 | $2.48 | $124k | 267,351 | Nov 27, 2024 |
| Nov 25, 2024 | Paul Bolno President and CEO | SOpen-market sale Ordinary Shares10b5-1 | -50,000 | $15.00 | $750k | 217,351 | Nov 27, 2024 |
| Nov 25, 2024 | Paul Bolno President and CEO | MOption exercise Share Option (right to buy)derivative10b5-1 | -50,000 | $0.00 | $0 | 47,778 | Nov 27, 2024 |
| Nov 15, 2024 | Paul Bolno President and CEO | SOpen-market sale Ordinary Shares10b5-1 | -51,234 | $14.32 | $734k | 217,351 | Nov 15, 2024 |
| Nov 8, 2024 | Chris Francis See Remarks | MOption exercise Ordinary Shares10b5-1 | +36,000 | $8.17 | $294k | 36,000 | Nov 13, 2024 |
| Nov 8, 2024 | Chris Francis See Remarks | SOpen-market sale Ordinary Shares10b5-1 | -36,000 | $16.00 | $576k | 0 | Nov 13, 2024 |
| Nov 8, 2024 | Chris Francis See Remarks | MOption exercise Share Option (right to buy)derivative10b5-1 | -36,000 | $0.00 | $0 | 0 | Nov 13, 2024 |
| Oct 16, 2024 | Paul Bolno President and CEO | SOpen-market sale Ordinary Shares10b5-1 | -90,474 | $15.00 | $1.4M | 268,585 | Oct 18, 2024 |
| Oct 16, 2024 | Chris Francis See Remarks | SOpen-market sale Ordinary Shares10b5-1 | -79,714 | $14.00 | $1.1M | 0 | Oct 18, 2024 |
| Oct 16, 2024 | Chris Francis See Remarks | MOption exercise Ordinary Shares10b5-1 | +40,997 | $2.48 | $102k | 40,997 | Oct 18, 2024 |
| Oct 16, 2024 | Chris Francis See Remarks | SOpen-market sale Ordinary Shares10b5-1 | -40,997 | $13.00 | $533k | 0 | Oct 18, 2024 |
| Oct 16, 2024 | Chris Francis See Remarks | MOption exercise Ordinary Shares10b5-1 | +65,625 | $3.14 | $206k | 65,625 | Oct 18, 2024 |
| Oct 16, 2024 | Chris Francis See Remarks | SOpen-market sale Ordinary Shares10b5-1 | -65,625 | $13.75 | $902k | 0 | Oct 18, 2024 |
| Oct 16, 2024 | Chris Francis See Remarks | MOption exercise Ordinary Shares10b5-1 | +22,500 | $2.83 | $64k | 22,500 | Oct 18, 2024 |
| Oct 16, 2024 | Chris Francis See Remarks | SOpen-market sale Ordinary Shares10b5-1 | -22,500 | $13.50 | $304k | 0 | Oct 18, 2024 |
| Oct 16, 2024 | Chris Francis See Remarks | MOption exercise Share Option (right to buy)derivative10b5-1 | -40,997 | $0.00 | $0 | 0 | Oct 18, 2024 |
| Oct 16, 2024 | Chris Francis See Remarks | MOption exercise Share Option (right to buy)derivative10b5-1 | -65,625 | $0.00 | $0 | 84,375 | Oct 18, 2024 |
| Oct 16, 2024 | Chris Francis See Remarks | MOption exercise Share Option (right to buy)derivative10b5-1 | -22,500 | $0.00 | $0 | 22,500 | Oct 18, 2024 |
| Oct 11, 2024 | Kyle Moran Chief Financial Officer | MOption exercise Ordinary Shares | +25,000 | $2.48 | $62k | 44,777 | Oct 11, 2024 |
| Oct 11, 2024 | Kyle Moran Chief Financial Officer | MOption exercise Share Option (right to buy)derivative | -25,000 | $0.00 | $0 | 0 | Oct 11, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Paul BolnoPresident and CEO
- Mark Corrigandirector
- Chris FrancisSee Remarks
- Christian O Henryofficer, director
- Kyle MoranChief Financial Officer
- Ra Capital Management, L.p.owner, director
- Adrian Rawcliffeceo, officer, director
- Ken Takanashidirector
- Aik Na Tandirector
- Gregory L. Verdinedirector
- Heidi L Wagnerdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.